Table 1 Clinical and pathological characteristics of the patients
Fertility-sparing surgery n:16 | Complete surgery n: 50 | Total n: 66 | P value | ||
|---|---|---|---|---|---|
Age (year) | Mean ± SD | 32.6 ± 6.76 | 54.05 ± 10.8 | 48.8 ± 13.6 | 0.001 |
BMI | Median (min-max) | 25.7 (21.2–34.3) | 26.3 (21.0–37.9) | 0.549 | |
Preop CA-125 | Median (min-max) | 52.0 (21.0–432) | 61 (4.2–6064) | 0.486 | |
Histological type | Serous | 0 (0%) | 12 (18.2%) | 12 (18.2%) | NA |
Mucinosis | 3 (4.5%) | 7 (10.6%) | 10 (15.2%) | ||
Endometrioid | 11 (16.7%) | 18 (27.3%) | 29 (43.9%) | ||
Clear | 2 (3.0%) | 9 (13.6%) | 11 (16.7%) | ||
Mix (serous + endometrioid) | 0 (0%) | 4 (6.1%) | 4.(6.1%) | ||
Stage | IA | 11 (16.7%) | 32 (48.5%) | 43 (65.2%) | NA |
IB | 0 (0%) | 1 (1.59%) | 1 (1.5%) | ||
IC1 | 2 (3%) | 7 (10.6%) | 9 (13.6%) | ||
IC2 | 2 (3%) | 2 (3%) | 4 (6.1%) | ||
IC3 | 1 (1.5%) | 8 (12.1%) | 9 (13.6%) | ||
Grade | I | 9 (13.6%) | 18 (27.3%) | 27 (40.9%) | 0.216 |
II | 4 (6.1%) | 11 (16.7%) | 15 (22.7%) | ||
III | 3 (54.5%) | 21 (31.8%) | 24 (36.4%) | ||
Lymph status | Yes | 16 (24.2%) | 42 (63.6%) | 58 (87.9%) | 0.183 |
No | 0 (0%) | 8 (12.1%) | 8 (12.1%) | ||
Recurrence status | Yes | 3 (4.5%) | 10 (15.2%) | 13 (19.7%) | 1.00 |
No | 13 (19.7%) | 40 (60.65%) | 53 (80.3%) | ||
Status | Live | 15 (22.7%) | 43 (65.2%) | 58 (87.9%) | 0.668 |
Death | 1 (1.5%) | 7 (10.6%) | 8 (12.1%) | ||
Adjuvant Chemotherapy | CT+ | 7 (10.6%) | 38 (57.6%) | 45 (68.2%) | 0.016 |
CT- | 9 (13.6%) | 12 (18.2%) | 21 (31.8%) | ||
Follow up | Median (min-max) | 93.9 (24.8–180.5) | 93.8 (6.9–181.4) | ||
Pregnancy status | Yes | 4 (25%) | |||
No | 12 (75%) |